COVID-19 has had a huge global impact, with the virus progressing at an alarming rate. As a leading biotechnology company with a platform technology, bio teams, bio facilities and manufacturing, Spartan is looking into how it can quickly contribute to the health efforts worldwide.
We are currently investigating how our rapid, sample-to-result DNA testing platform can be used to detect the COVID-19 virus in under an hour.
Spartan’s diagnostic platform is a CE IVD approved DNA analyzer. Its size and unique ability to go directly from sample to result from non-technical staff would be ideal for fast and portable detection of COVID-19 because it can be deployed in non-laboratory settings such as airports, cruise ships, military bases, and other critical points of entry. The CDC has developed a COVID-19 DNA test and Spartan is currently exploring how to perform the test on its platform.